Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177

Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been reported to have caused 18 [...]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Viruses 2022-07, Vol.14 (7), p.1526
Hauptverfasser: Jäger, Niklas, Hoffmann, Markus, Pöhlmann, Stefan, Krüger, Nadine
Format: Artikel
Sprache:eng
Schlagworte:
Comment
Conflicts of interest
Coronaviruses
COVID-19
COVID-19 infection
Cytotoxicity
etiological agents
Genomes
HIV
Human immunodeficiency virus
Infections
n/a
pandemic
Plasmids
Reading
Severe acute respiratory syndrome coronavirus 2
Topical application
Variance analysis
Vero cells
Virology
virus replication
Viruses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has been reported to have caused 18 [...]
ISSN:1999-4915
1999-4915
DOI:10.3390/v14071526